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ABSTRACT IMPACT: Indiana CTSI Team Science to maximize rapid collection, analyses 
and dissemination of biosamples collected from patients with Covid-19 to provide preliminary 
data for grant applications on the pathogenesis and outcomes of patients with Covid-19. 
OBJECTIVES/GOALS: When Covid-19 hit Indiana in April, there was an immediate need to 
respond rapidly to coordinate research across our healthcare systems. The CTSI became a point 
of contact for coordinating research endeavors including activation of clinical trials and use of 
precious samples from patients with Covid-19 to maximize preliminary data for grants. 
METHODS/STUDY POPULATION: The Indiana CTSI coordinated collection of biospecimens 
at multiple hospitals using in person and remote consenting via telephone or on a smartphone 
utilizing a QR code. We also retrieved existing samples from the Indiana Biobank previously 
collected for future research and from subject positive for Covid-19 by search of the linked 
electronic health record (EHR). A total of 224 subject samples (7 children, 36 previously 
collected, and 6 with both acute and recovered specimens) were obtained over a four month 
period. Our CTSI cores ran varied analyses collated to a single database, linked to the EMR for 
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use as preliminary data for grant applications to avoid redundancy of measures on limited 
samples. RESULTS/ANTICIPATED RESULTS: The 224 subject samples were used for whole 
exome DNA sequencing, RNA seq, analyses of 48 plasma cytokine/chemokines by multiplex 
analyses, and PBMC isolated for culture and assessment of secreted cytokines. The clinical data 
were linked and included demographics, hospitalization length of stay and need for mechanical 
ventilation, max and min oxygen levels, liver function tests, IL-6, D-dimer, CRP, LDH, and 
ferritin, need for dialysis, and echocardiography. Additional clinical data were available upon 
request. A survey was sent to our CTSI email to query for potential interest in the data with 87 
inquiries, and to date 46 investigators have requested data and/or additional samples. 
DISCUSSION/SIGNIFICANCE OF FINDINGS: During the first surge of Covid-19, the CTSI 
coordinated analyses for the dissemination of results for use by CTSI investigators to minimize 
duplication of assays and increase availability. The collaboration of research coordinators, 
biobank, research cores, and informatics demonstrates the power and agility of team science in 
the Indiana CTSI. 
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